Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02487160 · ClinicalTrials.gov registry record · Phase 3
Clinical Evaluation of the Lenstec SBL-3 Multifocal Intraocular Lens
A Phase 3 study, sponsored by Lenstec Incorporated.
- Completed
- Registry status
- Phase 3
- Development phase
- 499
- Enrollment target
NCT02487160 is a Phase 3 study that has completed, run by Lenstec Incorporated. The registered enrollment target is 499 participants.
The verdict
NCT02487160, a Phase 3 study, has completed, sponsored by Lenstec Incorporated.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 499 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and performance of the SBL-3 intraocular lens.
Interventions
- DEVICE SBL-3 multifocal intraocular lens
- DEVICE Control monofocal intraocular lens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 499 participants |
| Start Date | 2015-08 |
| Est. Completion | 2019-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02487160
The ClinicalTrials.gov registry entry for NCT02487160 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 499 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lenstec Incorporated, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which SBL-3 multifocal intraocular lens is the first listed.
NCT02487160 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02487160 about?
NCT02487160 is a clinical study titled "Clinical Evaluation of the Lenstec SBL-3 Multifocal Intraocular Lens". The purpose of this study is to evaluate the safety and performance of the SBL-3 intraocular lens.
What is the current status of trial NCT02487160?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 499 participants. The study started on 2015-08. Estimated completion is 2019-08.
What interventions are being tested in trial NCT02487160?
The interventions under investigation include: SBL-3 multifocal intraocular lens (DEVICE), Control monofocal intraocular lens (DEVICE).
Who is sponsoring clinical trial NCT02487160?
This trial is sponsored by Lenstec Incorporated, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.